Circulating osteopontin levels could predict infarct size in patients with ST-elevated MI [147], and a combination of high osteopontin levels and high hs-CRP levels were significantly associated with increased risk of all-cause mortality, re-infarction, and HF [148]. The gene discussed is SPP1; the disease is hydrops fetalis.